270 related articles for article (PubMed ID: 932524)
1. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
[TBL] [Abstract][Full Text] [Related]
2. Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis.
Ardaillou N; Yvart J; Le Bras P; Larrieu MJ
Thromb Haemost; 1980 Dec; 44(3):146-9. PubMed ID: 7466742
[TBL] [Abstract][Full Text] [Related]
3. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
Nieuwenhuizen W; Emeis JJ; Vermond A
Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
6. Studies on the control of sodium excretion in experimental uremia.
Schultze RG; Shapiro HS; Bricker NS
J Clin Invest; 1969 May; 48(5):869-77. PubMed ID: 5780197
[TBL] [Abstract][Full Text] [Related]
7. Decreased fractional renal excretion of gentamicin in subtotal nephrectomized dogs.
Riviere JE; Bowman KF; Rogers RA
J Pharmacol Exp Ther; 1985 Jul; 234(1):90-3. PubMed ID: 4009507
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen degradation products in acute renal failure of the newborn.
Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
[TBL] [Abstract][Full Text] [Related]
9. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
10. Renal catabolism of truncated glucagon-like peptide 1.
Ruiz-Grande C; Alarcón C; Alcántara A; Castilla C; López Novoa JM; Villanueva-Peñacarrillo ML; Valverde I
Horm Metab Res; 1993 Dec; 25(12):612-6. PubMed ID: 8119664
[TBL] [Abstract][Full Text] [Related]
11. The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments.
Wochner RD; Strober W; Waldmann TA
J Exp Med; 1967 Aug; 126(2):207-21. PubMed ID: 4165739
[TBL] [Abstract][Full Text] [Related]
12. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.
Dejana E; Languino LR; Polentarutti N; Balconi G; Ryckewaert JJ; Larrieu MJ; Donati MB; Mantovani A; Marguerie G
J Clin Invest; 1985 Jan; 75(1):11-8. PubMed ID: 3965498
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
[TBL] [Abstract][Full Text] [Related]
14. The clearance of human fibrinogen fragments X and Y in mice: a process mediated by the fragment D receptor.
Pasqua JJ; Pizzo SV
Thromb Haemost; 1983 Apr; 49(2):78-80. PubMed ID: 6306860
[TBL] [Abstract][Full Text] [Related]
15. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
16. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
Plow E; Edgington TS
J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
[TBL] [Abstract][Full Text] [Related]
17. Glucagon metabolism in the rat.
Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
[TBL] [Abstract][Full Text] [Related]
18. In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.
Hayne OA; Sherman LA
Am J Pathol; 1973 May; 71(2):219-38. PubMed ID: 4713941
[TBL] [Abstract][Full Text] [Related]
19. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.
Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M
J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
